HB3082: Relating to reporting obligations for patient assistance programs for prescription drug purchases.
Legislative Summary
Tells a person that makes drugs and offers help in paying for the drugs to report to a state agency the number of people who used the help the person offered. Tells the person to do the report even if the price of the drug did not go up. (Flesch Readability Score: 74.9). Requires prescription drug manufacturers to report to the Department of Consumer and Business Services the total number of consumers to which the manufacturer offered a patient assistance program who participated in the program, notwithstanding any increase in the price of the prescription drug for which the manufacturer offered the program.
Demographic Impact
Overall analysis of equity impact
Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.